{"Title": "CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes", "Year": 2018, "Source": "Cell. Mol. Immunol", "Volume": "15", "Issue": 2, "Art.No": null, "PageStart": 158, "PageEnd": 170, "CitedBy": 18, "DOI": "10.1038/cmi.2016.42", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041644552&origin=inward", "Abstract": "\u00a9 2018 CSI and USTC All rights reserved.CD5 is constitutively expressed on T cells and a subset of mature normal and leukemic B cells in patients with chronic lymphocytic leukemia (CLL). Important functional properties are associated with CD5 expression in B cells, including signal transducer and activator of transcription 3 activation, IL-10 production and the promotion of B-lymphocyte survival and transformation. However, the pathway(s) by which CD5 influences the biology of B cells and its dependence on B-cell receptor (BCR) co-signaling remain unknown. In this study, we show that CD5 expression activates a number of important signaling pathways, including Erk1/2, leading to IL-10 production through a novel pathway independent of BCR engagement. This pathway is dependent on extracellular calcium (Ca 2+) entry facilitated by upregulation of the transient receptor potential channel 1 (TRPC1) protein. We also show that Erk1/2 activation in a subgroup of CLL patients is associated with TRPC1 overexpression. In this subgroup of CLL patients, small inhibitory RNA (siRNA) for CD5 reduces TRPC1 expression. Furthermore, siRNAs for CD5 or for TRPC1 inhibit IL-10 production. These findings provide new insights into the role of CD5 in B-cell biology in health and disease and could pave the way for new treatment strategies for patients with B-CLL.", "AuthorKeywords": ["B cells", "calcium", "CD5", "MAPK/Erk", "TRPC1"], "IndexKeywords": ["Aged", "Aged, 80 and over", "B-Lymphocytes", "Calcium", "CD5 Antigens", "Cell Line, Tumor", "Female", "Humans", "Interleukin-10", "Leukemia, Lymphocytic, Chronic, B-Cell", "Male", "MAP Kinase Signaling System", "Middle Aged", "Models, Biological", "Phosphorylation", "Receptors, Antigen, B-Cell", "Transcriptome", "TRPC Cation Channels", "Up-Regulation"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85041644552", "SubjectAreas": [["Immunology and Allergy", "MEDI", "2723"], ["Immunology", "IMMU", "2403"], ["Infectious Diseases", "MEDI", "2725"]], "AuthorData": {"22334405300": {"Name": "Garaud S.", "AuthorID": "22334405300", "AffiliationID": "60105495, 60017186, 60000905", "AffiliationName": "INSERM ERI29/EA2216, Reseau Epigenetique and Reseau Canaux Ioniques du Canceropole Grand Ouest, Brest University Medical School"}, "56656482500": {"Name": "Debant M.", "AuthorID": "56656482500", "AffiliationID": "60105495, 60017186, 60000905", "AffiliationName": "INSERM ERI29/EA2216, Reseau Epigenetique and Reseau Canaux Ioniques du Canceropole Grand Ouest, Brest University Medical School"}, "56078880200": {"Name": "Melayah S.", "AuthorID": "56078880200", "AffiliationID": "60105495, 60017186, 60000905", "AffiliationName": "INSERM ERI29/EA2216, Reseau Epigenetique and Reseau Canaux Ioniques du Canceropole Grand Ouest, Brest University Medical School"}, "7006949958": {"Name": "Berthou C.", "AuthorID": "7006949958", "AffiliationID": "60105495, 60017186, 60000905", "AffiliationName": "INSERM ERI29/EA2216, Reseau Epigenetique and Reseau Canaux Ioniques du Canceropole Grand Ouest, Brest University Medical School"}, "6604006201": {"Name": "Pers J.O.", "AuthorID": "6604006201", "AffiliationID": "60105495, 60017186, 60000905", "AffiliationName": "INSERM ERI29/EA2216, Reseau Epigenetique and Reseau Canaux Ioniques du Canceropole Grand Ouest, Brest University Medical School"}, "55646974200": {"Name": "Luque-Paz D.", "AuthorID": "55646974200", "AffiliationID": "60025999", "AffiliationName": "Laboratory of Immunology and Immunotherapy, CHU Morvan"}, "55541557500": {"Name": "Youinou P.", "AuthorID": "55541557500", "AffiliationID": "60105495, 60017186, 60000905", "AffiliationName": "INSERM ERI29/EA2216, Reseau Epigenetique and Reseau Canaux Ioniques du Canceropole Grand Ouest, Brest University Medical School"}, "6701653641": {"Name": "Renaudineau Y.", "AuthorID": "6701653641", "AffiliationID": "60025999", "AffiliationName": "Laboratory of Immunology and Immunotherapy, CHU Morvan"}, "36741071000": {"Name": "Taher T.E.", "AuthorID": "36741071000", "AffiliationID": "60021435, 60022109", "AffiliationName": "Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London"}, "7006516084": {"Name": "Mageed R.A.", "AuthorID": "7006516084", "AffiliationID": "60021435, 60022109", "AffiliationName": "Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London"}, "15924845500": {"Name": "Burgos M.", "AuthorID": "15924845500", "AffiliationID": "60105649, 60000905", "AffiliationName": "Canalopathy and Calcium Signaling, INSERM UMR1078"}, "6602175115": {"Name": "Mignen O.", "AuthorID": "6602175115", "AffiliationID": "60105649, 60000905", "AffiliationName": "Canalopathy and Calcium Signaling, INSERM UMR1078"}, "23976586800": {"Name": "Parikh K.", "AuthorID": "23976586800", "AffiliationID": "60001157", "AffiliationName": "Centre for Experimental and Molecular Medicine, Academic Medical Center"}, "55068614500": {"Name": "Chiocchia G.", "AuthorID": "55068614500", "AffiliationID": "60031594, 60000905", "AffiliationName": "Institut Cochin, INSERM U567"}, "7005062812": {"Name": "Peppelenbosch M.", "AuthorID": "7005062812", "AffiliationID": "60032114", "AffiliationName": "Department of Gastroenterology and Hepatology, Erasmus MC"}, "36051280800": {"Name": "Isenberg D.A.", "AuthorID": "36051280800", "AffiliationID": "60022148", "AffiliationName": "Centre for Rheumatology, University College London"}}}